Advisory Committee on Immunization Practices: Notice of Charter Amendment, 5115 [2015-01767]

Download as PDF 5115 Federal Register / Vol. 80, No. 20 / Friday, January 30, 2015 / Notices project period and one retrospective data collection during the first year of the three-year project period. The retrospective data collection will provide information about clients’ baseline characteristics prior to participation in the model program which is needed to compare outcomes before and after program implementation. Minor formatting revisions are requested to the previously approved data collection forms. Lastly, CDC newly requests approval to conduct key informant interviews with program clinic and pharmacy staff in order to evaluate the program processes and to collect time and cost data which will be used to estimate the cost of the The data collection will allow CDC to conduct continuous program performance monitoring which includes identification of barriers to program implementation, solutions to those barriers, and documentation of client health outcomes. Performance monitoring will allow the model program to be adjusted, as needed, in order to develop a final implementation model that is self-sustaining and which can be used to establish similar collaborations in a variety of clinical settings. Collection of cost data will allow for the cost of the program to be estimated. There is no cost to participants other than their time. model program. The key informant interviews and time and cost data are additional data collections from the original OMB approval. Pharmacy, laboratory and medical data will be collected through abstraction of all participant clients’ pharmacy and medical records. Pharmacy, laboratory and medical data are needed to monitor retention in care, adherence to therapy, viral load suppression and other health outcomes. Program specific data, such as the number of MTM elements completed per project site and time spent on program activities, will be collected by program. Qualitative data will be gathered from program staff through inperson or telephone interviews. ESTIMATED ANNUALIZED BURDEN HOURS Number of respondents Number of responses per respondent Average burden per response (in hours) Total burden (in hours) Type of respondent Form name Clinic Data Manager ...... Pharmacist ..................... Clinic Data Manager ...... Clinic Data Manager ...... Clinic Data Manager ...... Pharmacist ..................... Key informants ............... Clinic staff ...................... Pharmacy staff ............... Project clinic characteristics form ........................ Project pharmacy characteristics form ................ Patient Demographic Information form ............... Initial patient information form ............................. Quarterly patient information form ....................... Pharmacy record abstraction form ...................... Interviewer data collection worksheet ................. Clinic cost form .................................................... Pharmacy cost form ............................................ 10 10 10 10 10 10 60 20 20 3 3 100 100 400 400 2 2 2 30/60 30/60 5/60 1 30/60 30/60 30/60 10 10 15 15 83 1,000 2,000 2,000 60 400 400 Total ........................ .............................................................................. ........................ ........................ ........................ 5,973 Leroy A. Richardson, Chief, Information Collection Review Office, Office of Scientific Integrity, Office of the Associate Director for Science, Office of the Director, Centers for Disease Control and Prevention. [FR Doc. 2015–01698 Filed 1–29–15; 8:45 am] BILLING CODE 4163–18–P DEPARTMENT OF HEALTH AND HUMAN SERVICES Centers for Disease Control and Prevention asabaliauskas on DSK5VPTVN1PROD with NOTICES Advisory Committee on Immunization Practices: Notice of Charter Amendment This gives notice under the Federal Advisory Committee Act (Pub. L. 92– 463) of October 6, 1972, that the Advisory Committee on Immunization Practices, Centers for Disease Control and Prevention (CDC), Department of Health and Human Services (HHS), has amended their charter to reflect the change in the filing date. The amended filing date is January 13, 2015. VerDate Sep<11>2014 18:50 Jan 29, 2015 Jkt 235001 For information, contact Dr. Larry Pickering, Designated Federal Officer, Advisory Committee on Immunization Practices, HHS, CDC, 1600 Clifton Road NE., Mailstop E05, Atlanta, Georgia 30333, telephone (404) 639–8562 or fax (404) 639–8626. The Director, Management Analysis and Services Office, has been delegated the authority to sign Federal Register notices pertaining to announcements of meetings and other committee management activities, for both the Centers for Disease Control and Prevention and the Agency for Toxic Substances and Disease Registry. Elaine L. Baker, Director, Management Analysis and Services Office, Centers for Disease Control and Prevention. [FR Doc. 2015–01767 Filed 1–29–15; 8:45 am] BILLING CODE 4163–18–P PO 00000 Frm 00036 Fmt 4703 Sfmt 4703 DEPARTMENT OF HEALTH AND HUMAN SERVICES Centers for Disease Control and Prevention Advisory Committee to the Director (ACD), Centers for Disease Control and Prevention—Health Disparities Subcommittee (HDS) In accordance with section 10(a)(2) of the Federal Advisory Committee Act (Pub. L. 92–463), the Centers for Disease Control and Prevention (CDC) announces the following meeting of the aforementioned subcommittee: Time and Date: 11:00 a.m.–12:30 p.m. EST, February 26, 2015. Place: This meeting will be held by teleconference. Status: This meeting is open to the public, limited only by the availability of telephone ports. The public is welcome to participate during the public comment, which is tentatively scheduled from 12:15 to 12:30 p.m. To participate in the teleconference, please dial (866) 763–0273 Passcode: 6158968. Purpose: The Subcommittee will provide advice to the CDC Director through the ACD on strategic and other health disparities and E:\FR\FM\30JAN1.SGM 30JAN1

Agencies

[Federal Register Volume 80, Number 20 (Friday, January 30, 2015)]
[Notices]
[Page 5115]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: 2015-01767]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

Centers for Disease Control and Prevention


Advisory Committee on Immunization Practices: Notice of Charter 
Amendment

    This gives notice under the Federal Advisory Committee Act (Pub. L. 
92-463) of October 6, 1972, that the Advisory Committee on Immunization 
Practices, Centers for Disease Control and Prevention (CDC), Department 
of Health and Human Services (HHS), has amended their charter to 
reflect the change in the filing date. The amended filing date is 
January 13, 2015.
    For information, contact Dr. Larry Pickering, Designated Federal 
Officer, Advisory Committee on Immunization Practices, HHS, CDC, 1600 
Clifton Road NE., Mailstop E05, Atlanta, Georgia 30333, telephone (404) 
639-8562 or fax (404) 639-8626.
    The Director, Management Analysis and Services Office, has been 
delegated the authority to sign Federal Register notices pertaining to 
announcements of meetings and other committee management activities, 
for both the Centers for Disease Control and Prevention and the Agency 
for Toxic Substances and Disease Registry.

Elaine L. Baker,
Director, Management Analysis and Services Office, Centers for Disease 
Control and Prevention.
[FR Doc. 2015-01767 Filed 1-29-15; 8:45 am]
BILLING CODE 4163-18-P

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.